信頼性の高い免疫細胞アッセイの開発には、十分な科学的知識と最適化のために時間への投資が必要です。免疫細胞のスクリーニングでは、アッセイ性能のばらつきや信頼性の低いデータを低減して再現性のある結果を得るために、正確かつ一貫したハンドリングが求められます。
Horizonをご利用いただければ、ご希望のアッセイに対する堅牢なデータセットを得られます。十分なリソースをおもちでなくとも、免疫細胞に対する専門性と専用機器を備えたHorizonがお客様のプロジェクトをサポートします。
Immune cell screen DD flow

Immune cell screen projects

Identify relevant genes by genomic CRISPRko screening  in primary human lymphocytes, with functional readouts

  • Design guides and identify genes relevant to your model 

  • Gather data from cell surface markers and protein release
  • Explore imaging and functional readouts at high throughput 
ImmuSignature DD flow

Compound screening by ImmuSignature assays

Swiftly evaluate the efficacy of lead therapeutics in immune cell-based environments using standardized compound screening assays.

  • Assess the immunological effects of drug candidates  

  • Ensure safety through immunotoxicity analysis 
  • Obtain dose-response data on proliferation or suppression in weeks 

Webinar: 初代免疫細胞における遺伝子調節

Custom assay capabilities

Partner with our experts to tackle your complex immune cell projects.  

  • Increased efficiency for your workflow
  • Specialized access to skills and knowledge
  • Fully scalable and flexible to fit your needs

T細胞のCRISPRゲノム編集

初代ヒトT細胞でCRISPRゲノム編集を成功させるためのヒントと検討事項を学びます。

Why exploring the epigenetics of T cell exhaustion through immune cell screening is so powerful

Learn about how T cell exhaustion poses a significant challenge in immuno-oncology and the way epigenetic mechanisms can help develop strategies for reinvigorating exhausted T cells.

What you need to know when submitting an Investigational New Drug application

With the requirement of thorough in vitro assays and high throughput screening technologies to ensure drug safety and efficacy, make sure you're fully ready for when you submit your IND application by assessing immunogenicity with an MLR assay